## **What is an implantable tissue marker?**
An implantable tissue marker is a small device, commonly a gold seed or other biocompatible material, placed within tissue to precisely mark a treatment site, typically to guide radiation therapy or diagnostic imaging. These markers serve as fixed points of reference, enabling physicians to target tumours and surrounding tissues with high precision, particularly during radiation therapy or other stereotactic techniques.
Unlike temporary markers, an implantable tissue marker remains inside the patient's body, ensuring accurate alignment across multiple treatment sessions. This is particularly critical when managing cancers of the prostate, breast, liver, or lungs, where even slight shifts in tumor position could reduce treatment effectiveness.
Placement is usually performed by a physician, such as a urologist, who may use a CPT code like 55876 (placement of interstitial devices) for the procedure. The marker supply is billed separately using HCPCS code A4648 (tissue marker, implantable, any type, each).
By ensuring consistent visualization of the treatment site across imaging studies, tissue marker implantables improve accuracy, reduce the risk of radiation exposure to healthy organs, and ultimately enhance patient outcomes.
## **HCPCS code A4648 documentation requirements**
Documentation for HCPCS Code A4648 must demonstrate medical necessity and the procedural context for marker use. Key requirements include:
- A clinical indication supporting placement, such as tumor localization for radiation therapy guidance.
- A procedure note confirming the insertion of an implantable tissue marker (e.g., gold seed marker).
- Documentation linking the marker to a qualifying CPT procedure, most commonly CPT 55876. Other placement codes (e.g., 32553 for thoracic marker placement or 49411 for abdominal guidance) may also apply when clinically appropriate.
- Medicare requires A4648 to be billed on the same date of service as a valid CPT placement code. Claims for A4648 submitted without an accompanying placement procedure on the same day are denied as non-payable.
## **A4648 billing requirements**
Key points in billing:
- **Unit of service**: One unit represents one implantable tissue marker
- **Bundling**: Under the outpatient prospective payment system (OPPS) and ambulatory xurgical center (ASC) payment systems, A4648 is typically packaged into the payment for the associated placement procedure and is not separately reimbursed.
- **Medicare coverage**: Payment is allowed only when paired with a valid CPT placement code on the same date of service; otherwise, the marker is non-payable.
- **Payer variations**: Commercial insurers may follow different bundling or coverage rules, so always verify payer-specific policy before submitting claims.
## **Other relevant codes**
Related CPT placement codes include:
- **CPT 55876** – Placement of interstitial device(s) for radiation therapy guidance (e.g., gold seed markers in the prostate).
- **CPT 32553** – Placement of interstitial device(s) for radiation therapy guidance, percutaneous, intrathoracic.
- **CPT 49411** – Placement of interstitial device(s) for radiation therapy guidance, percutaneous, intra-abdominal.
- **CPT 19499** – Unlisted procedure, breast; sometimes used for tissue marker placement during breast procedures when no specific CPT code exists.
### **Related HCPCS and ICD-10 codes**
- **HCPCS A4648** – Tissue marker, implantable, any type, each (supply code).
- **ICD-10-CM Z51.0** – Encounter for antineoplastic radiation therapy (often used with marker placement).
- **ICD-10-CM C61** – Malignant neoplasm of prostate (commonly linked to gold seed marker use in prostate cancer).
Frequently asked questions
